Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/9671| Title: | Efficacy and safety of levofloxacin in the outpatient treatment of exacerbation of chronic obstructive pulmonary disease: levofloxacin 750 mg vs. levofloxacin 500 mg | Authors: | Minov, J Stoleski, S Petrova, T Vasilevska, K Mijakoski, D Karadzinska-Bislimovska, J |
Keywords: | bacterial exacerbation chronic obstructive pulmonary disease clinical success rate levofloxacin relaps side effects |
Issue Date: | 2020 | Publisher: | Open Access Text Pvt, Ltd. | Journal: | Health and Primary Care | URI: | http://hdl.handle.net/20.500.12188/9671 | DOI: | 10.15761/hpc.1000184 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Efficacy and safety of levofloxacin in the outpatient treatment of exacerbation of COPD levofloxacin 750 vs 500 mg_HPC-4-184.pdf | 331.14 kB | Adobe PDF | View/Open |
Page view(s)
100
checked on Jul 24, 2024
Download(s)
113
checked on Jul 24, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.